GSA CAPITAL PARTNERS LLP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$402
-74.6%
126,812
-49.6%
0.03%
-82.7%
Q4 2022$1,581
-99.5%
251,384
+689.4%
0.20%
+326.1%
Q3 2022$344,000
-74.6%
31,846
-78.6%
0.05%
-74.7%
Q1 2022$1,356,000
-20.8%
148,804
+29.6%
0.18%
-15.3%
Q4 2021$1,713,000
+370.6%
114,815
+723.0%
0.22%
+424.4%
Q2 2021$364,000
+27.7%
13,951
+23.8%
0.04%
-12.8%
Q4 2020$285,000
+3.3%
11,273
+6.1%
0.05%
+46.9%
Q4 2019$276,00010,6220.03%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders